Officer exercised or converted 2,500 WST derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 14, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 15, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000110
Filed / recordedSep 15, 2026, 8:37 PM UTCAdded to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personAnnette F Favorite Officer titleSr. VP & Chief HR Officer SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateSep 14, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $863K of West Pharmaceutical Services shares. Nobody planned it ahead of time.